Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis.
作者信息
Khan Faizan, Carrier Marc, Rochwerg Bram
出版信息
JACC CardioOncol. 2024 Jul 2;6(4):622-623. doi: 10.1016/j.jaccao.2024.03.014. eCollection 2024 Aug.
Abstract
摘要
相似文献
1
Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis.评估抗凝剂用于癌症相关血栓形成的疗效和安全性的证据确定性
JACC CardioOncol. 2024 Jul 2;6(4):622-623. doi: 10.1016/j.jaccao.2024.03.014. eCollection 2024 Aug.
2
Anticoagulation for people with cancer and central venous catheters.癌症患者及中心静脉导管置入者的抗凝治疗
Cochrane Database Syst Rev. 2018 Jun 1;6(6):CD006468. doi: 10.1002/14651858.CD006468.pub6.
3
Reply: Assessing the Certainty of Evidence on Efficacy and Safety of Anticoagulants for Cancer-Associated Thrombosis.回复：评估抗凝剂用于癌症相关血栓形成的疗效和安全性的证据确定性
JACC CardioOncol. 2024 Jul 2;6(4):624. doi: 10.1016/j.jaccao.2024.05.014. eCollection 2024 Aug.
4
Anticoagulation for perioperative thromboprophylaxis in people with cancer.癌症患者围手术期血栓预防的抗凝治疗
Cochrane Database Syst Rev. 2018 Jul 11;7(7):CD009447. doi: 10.1002/14651858.CD009447.pub3.
5
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.癌症患者在无抗凝治疗或预防指征的情况下使用口服抗凝药物。
Cochrane Database Syst Rev. 2021 Oct 8;10(10):CD006466. doi: 10.1002/14651858.CD006466.pub7.
6
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.在无抗凝治疗或预防指征的癌症患者中进行口服抗凝治疗。
Cochrane Database Syst Rev. 2017 Dec 29;12(12):CD006466. doi: 10.1002/14651858.CD006466.pub6.
7
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.多发性骨髓瘤患者接受免疫调节剂治疗时的门诊抗血栓治疗。
Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD014739. doi: 10.1002/14651858.CD014739.
8
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
9
Parenteral anticoagulation in ambulatory patients with cancer.癌症门诊患者的胃肠外抗凝治疗
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD006652. doi: 10.1002/14651858.CD006652.pub5.
10
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.口服直接凝血酶抑制剂或口服因子 Xa 抑制剂与传统抗凝剂治疗肺栓塞的比较。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010957. doi: 10.1002/14651858.CD010957.pub3.
本文引用的文献
1
Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer: A Systematic Review and Meta-Analysis.比较与活动性癌症相关的静脉血栓栓塞的抗凝策略：一项系统评价和荟萃分析。
JACC CardioOncol. 2024 Jan 9;6(1):99-113. doi: 10.1016/j.jaccao.2023.10.009. eCollection 2024 Feb.
2
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
3
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis.用于对网络荟萃分析中治疗效果估计质量进行评级的GRADE工作组方法。
BMJ. 2014 Sep 24;349:g5630. doi: 10.1136/bmj.g5630.
Zotero 插件